XCUR - Exicure Corp Stock Price

Exicure, Inc. relies on global partnerships with pharmaceutical leaders to develop oligonucleotide drugs and secure commercial licensing. This chart reflects a current market value of 1.06, while business success remains contingent upon attracting investors and the efficiency of the SNA platform. The company is currently updating its R&D portfolio, developing targeted treatments for orphan diseases to overcome research stagnation.

exicuretx.com - XCUR Stock Price (period 07/04/2022 - 11/13/2026)

Exicure Corp (XCUR) - metric breakdowns and financial figures

- current price and projected stock value:

Stock Quotes Exicure, Inc.|XCUR - Broker Consensus Forecast

- market capitalization statistics:

Market Capitalization Exicure Inc.|XCUR - Real Price to Acquire Entire Company

- book capitalization information:

Accounting Value per Share Exicure|XCUR - Book Capitalization|Market Value to Book Value Ratio exicuretx.com|XCUR - Aggregate Asset Value

- issuer credit burden and liquidity indicators:

- financial results and valuation multiples details:

XCUR - Company Profit|Projected Future Earnings Exicure, Inc.|XCUR - Business Payback Period|Forward P/E Multiple Exicure, Inc.|XCUR - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Exicure Inc.|XCUR - Operating profit EBITDA|Earnings per share for the last twelve months Exicure|XCUR - Earnings per share for the trailing year|Quarterly EPS earnings growth exicuretx.com|XCUR - Earnings per share growth rate in current year|Expected earnings per share growth for next year Exicure, Inc.

Summary company analytics:Exicure

Given the lack of revenue and the restructuring of Exicure, Inc. (XCUR), the current price chart reflects speculative odds of finding a strategic partner rather than operational efficiency. This metric measures the market value of business ownership, transforming investor expectations into a specific figure, which allows for an assessment of the level of confidence in the issuer's ability to raise capital.

Analysis of competing companies